IP Library › Granted Patent US 12,502,557
Granted Patent B2
US 12,502,557 · App. 17/594,654 · Granted Dec 23, 2025

Radiotherapy devices and access authorisation

Inventors: Colin Winfield (Crawley, GB); Marco Massai (Crawley, GB); Neil Pritchard (Crawley, GB); Paul Boxall (Crawley, GB)
Assignee: Elekta Limited
A61N5/1075A61B90/98A61N2005/1074
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,502,557
App. No.
17/594,654
Granted
Dec 23, 2025
Kind
B2
Abstract

A method of determining whether a radiotherapy device configured to provide therapeutic radiation to a patient should be authorised for use. The device comprises a plurality of components, each component of the plurality of components being coupled with at least one identifier configured to provide data identifying the component it is coupled with. The method comprises receiving, from the identifiers, data identifying each of the plurality of components of the radiotherapy device and determining whether at least one authorisation criterion is met based on the identifying data and authorisation data; and if the at least one authorisation criterion is met, determining that the radiotherapy device is authorised for use.

Claims (65)

1 . A computer-implemented method of determining whether a radiotherapy device configured to provide therapeutic radiation to a patient should be authorized for use, the device comprising one or more components, each component of the one or more components being coupled with at least one identifier configured to provide data identifying the component it is coupled with; the method comprising:

receiving, from the at least one identifier, data identifying each of the one or more components of the radiotherapy device;

determining whether at least one authorization criterion is met based on the identifying data and authorization data;

in response to determining that the at least one authorization criterion is met, determining that the radiotherapy device is authorized for use;

maintaining a data log to store the received data identifying each component of the one or more components;

receiving data identifying a newly installed component of the radiotherapy device from an identifier coupled with the newly installed component;

determining that the newly installed component has been newly installed based on the received identifying data and data stored in the data log;

determining whether the at least one authorization criterion is met based on the identifying data received from the newly installed component and the authorization data;

in response to determining the at least one authorization criterion is met based on the identifying data received from the newly installed component and the authorization data, determining that the radiotherapy device is authorized for use, wherein each identifier of the at least one identifier comprises a power supply and an active transmitter configured to repeatedly transmit the data identifying the component, wherein the radiotherapy device comprises a receiver to receive one or more signals from the active transmitter, wherein a location of each of the one or more components is derived from the data log based on a strength of signals received at the receiver;

determining a signal strength when receiving data identifying a component from the active transmitter;

logging the signal strength and the received identifying data in the data log; and

in response to determining that the radiotherapy device is not authorized for use, causing the radiotherapy device to stop or shut down.

2 . The method of claim 1 , wherein the at least one identifier is one of a passive RFID tag, an active RFID tag, an optical mark, or a physical mark.

3 . The method of claim 1 , wherein determining whether at least one authorization criterion is met comprises checking that each of the one or more components identified by the identifying data is listed as being authorized for use with the radiotherapy device in an authorization database.

4 . The method of claim 1 , further comprising:

in response to determining that the at least one authorization criterion is not met, determining that the radiotherapy device is not authorized for use.

5 . The method of claim 4 , wherein, in response to determining that the radiotherapy device is not authorized, the method further comprises at least one of:

sending an indication which indicates that the device is not authorized to a device owner,

sending an indication that the device is not authorized to a device manufacturer, and

updating an authorization database to indicate that the device is not authorized for use.

6 . The method of claim 1 , wherein the radiotherapy device comprises a second receiver to receive one or more signals from the active transmitter, wherein maintaining the data log comprises logging a signal strength of the identifying data received at the receiver and the second receiver, and wherein the location of the component can be determined in at least two coordinate axes.

7 . The method of claim 1 , wherein the authorization data comprises an expected location of at least one of the one or more components, and wherein the at least one authorization criterion comprises a distance threshold such that determining whether the at least one authorization criterion is met comprises comparing the determined location of a component to the expected location of the component based on the distance threshold.

8 . The method of claim 1 , further comprising providing, in response to a user request, a last-known location of one or more components of the one or more components.

9 . The method of claim 1 , further comprising:

connecting the power supply of each identifier of the at least one identifier with a device power source;

determining that a particular component of the one or more components has been disconnected from the device power source; and

continuing to receive identifying data and log the signal strength and the received identifying data in the data log.

10 . The method of claim 1 , further comprising:

deriving from the data log a duration of instalment of each of the one or more components, wherein the authorization data comprises an operational lifetime of at least one of the one or more components, and wherein the at least one authorization criterion comprises an instalment time threshold wherein determining whether the at least one authorization criterion is met comprises comparing the duration of instalment to the operational lifetime based on the instalment time threshold.

11 . A computer-implemented method of determining whether a radiotherapy device configured to provide therapeutic radiation to a patient should be authorized for use, the device comprising one or more components, each component of the one or more components being coupled with at least one identifier configured to provide data identifying the component it is coupled with, the method comprising:

receiving, from the at least one identifier, data identifying each of the one or more components of the radiotherapy device;

sending the identifying data to a central processor to determine whether at least one authorization criterion is met based on the identifying data and authorization data;

receiving an indication which indicates whether the radiotherapy device is authorized for use;

maintaining a data log to store the received data identifying each component of the one or more components;

receiving data identifying a newly installed component of the radiotherapy device from an identifier coupled with the newly installed component;

determining that the newly installed component has been newly installed based on the received identifying data and data stored in the data log;

determining whether the at least one authorization criterion is met based on the identifying data received from the newly installed component and the authorization data;

in response to determining the at least one authorization criterion is met based on the identifying data received from the newly installed component and the authorization data, determining that the radiotherapy device is authorized for use, wherein each identifier of the at least one identifier comprises a power supply and an active transmitter configured to repeatedly transmit the data identifying the component, wherein the radiotherapy device comprises a receiver to receive one or more signals from the active transmitter;

determining a signal strength when receiving data identifying a component from the active transmitter;

logging the signal strength and the received identifying data in the data log; and

in response to determining that the radiotherapy device is not authorized for use, causing the radiotherapy device to stop or shut down.

12 . The method of claim 11 , wherein the at least one identifier is one of a passive RFID tag, an active RFID tag, an optical mark, or a physical mark.

13 . The method of claim 11 , further comprising:

maintaining a data log to store the received data identifying each component of the one or more components.

14 . The method of claim 11 , further comprising:

deriving from the data log a duration of instalment of each of the one or more components, wherein the authorization data comprises an operational lifetime of at least one of the one or more components, and wherein the at least one authorization criterion comprises an instalment time threshold wherein determining whether the at least one authorization criterion is met comprises comparing the duration of instalment to the operational lifetime based on the instalment time threshold.

15 . A radiotherapy device configured to provide therapeutic radiation to a patient, the device comprising:

one or more components, each component of the one or more components being coupled with at least one identifier, wherein the at least one identifier provides data identifying a particular component that the at least one identifier is coupled with; and

a device processor coupled to a device memory storing computer executable instructions which, when executed by the device processor, cause the device processor to perform operations comprising:

receiving, from the at least one identifier, data identifying each component of the one or more components of the radiotherapy device;

determining whether at least one authorization criterion is met based on the identifying data and authorization data;

responsive to determining that the at least one authorization criterion is met, determining that the radiotherapy device is authorized for use;

maintaining a data log to store the received data identifying each component of the one or more components;

receiving data identifying a newly installed component of the radiotherapy device from an identifier coupled with the newly installed component;

determining that the newly installed component has been newly installed based on the received identifying data and data stored in the data log;

determining whether the at least one authorization criterion is met based on the identifying data received from the newly installed component and the authorization data;

in response to determining the at least one authorization criterion is met based on the identifying data received from the newly installed component and the authorization data, determining that the radiotherapy device is authorized for use, wherein each identifier of the at least one identifier comprises a power supply and an active transmitter configured to repeatedly transmit the data identifying the component, and wherein the radiotherapy device comprises a receiver to receive one or more signals from the active transmitter, wherein a location of each of the one or more components is derived from the data log based on a strength of signals received at the receiver;

determining a signal strength when receiving data identifying a component from the active transmitter;

logging the signal strength and the received identifying data in the data log; and

in response to determining that the radiotherapy device is not authorized for use, causing the radiotherapy device to stop or shut down.

16 . The device of claim 15 , the radiotherapy device further comprising:

at least one additional receiver.

17 . The device of claim 16 , wherein the receiver is an RFID tag interrogator.

18 . The radiotherapy device of claim 15 , wherein the operations further comprise:

deriving from the data log a duration of instalment of each of the one or more components, wherein the authorization data comprises an operational lifetime of at least one of the one or more components, and wherein the at least one authorization criterion comprises an instalment time threshold wherein determining whether the at least one authorization criterion is met comprises comparing the duration of instalment to the operational lifetime based on the instalment time threshold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2021
From: WINFIELD, COLIN; MASSAI, MARCO; PRITCHARD, NEIL; BOXALL, PAUL
To: ELEKTA LIMITED
Reel/Frame 058364/0709 →
Priority Claims (1)
GB 1905783 · Apr 25, 2019 · national
Continuity (1)
Related Publication 20220088415A1 · Mar 24, 2022
References Cited (52)
US 5041789A · Keller · 1991 [cited by examiner]
US 5260581A · Lesyna et al. · 1993 [cited by applicant]
US 6085154A · Leuthausser · 2000 [cited by examiner]
US 7345292B2 · Moriyama et al. · 2008 [cited by applicant]
US 8560160B2 · Holzer · 2013 [cited by examiner]
US 9618461B2 · Ohara · 2017 [cited by examiner]
US 10204245B1 · Diorio et al. · 2019 [cited by applicant]
US 10327730B2 · Meiler · 2019 [cited by examiner]
US 10898734B2 · Taminiau · 2021 [cited by examiner]
US 20030097229A1 · Herrmann et al. · 2003 [cited by applicant]
US 20050035861A1 · Gliessmann et al. · 2005 [cited by applicant]
US 20060129140A1 · Todd · 2006 [cited by examiner]
US 20070257800A1 · Yang · 2007 [cited by examiner]
US 20080128492A1 · Roth et al. · 2008 [cited by applicant]
US 20080184330A1 · Lal et al. · 2008 [cited by applicant]
US 20080191009A1 · Gressel · 2008 [cited by examiner]
US 20080230608A1 · Lallemang · 2008 [cited by examiner]
US 20090171184A1 · Jenkins · 2009 [cited by examiner]
US 20110301671A1 · Lytle et al. · 2011 [cited by applicant]
US 20140055148A1 · Biber · 2014 [cited by examiner]
US 20140084058A1 · Barry · 2014 [cited by examiner]
US 20140221815A1 · Aklan · 2014 [cited by examiner]
US 20140341351A1 · Berwick · 2014 [cited by examiner]
US 20150130593A1 · Mats · 2015 [cited by examiner]
US 20160047872A1 · Park · 2016 [cited by examiner]
US 20160321422A1 · Albright · 2016 [cited by applicant]
US 20170359101A1 · Sabacinski · 2017 [cited by examiner]
US 20190006039A1 · Ali · 2019 [cited by applicant]
US 20190012479A1 · Diaz Carmena · 2019 [cited by examiner]
US 20200345437A1 · Rosa · 2020 [cited by examiner]
US 20210050099A1 · Kirshenbaum · 2021 [cited by examiner]
US 20210050102A1 · Avraham · 2021 [cited by examiner]
US 20210092823A1 · Koba · 2021 [cited by examiner]
US 20220088415A1 · Winfield · 2022 [cited by examiner]
US 20220375709A1 · Allen · 2022 [cited by examiner]
US 20230280288A1 · An · 2023 [cited by examiner]
US 20230307117A1 · Kumar · 2023 [cited by examiner]
US 20240080963A1 · Takanaka · 2024 [cited by examiner]
US 20240206044A1 · Pronk · 2024 [cited by examiner]
US 20240233931A1 · Dinh · 2024 [cited by examiner]
US 20240422887A1 · Vogtmeier · 2024 [cited by examiner]
US 20250024577A1 · Korst · 2025 [cited by examiner]
DE 102018204815A1 · 2018 [cited by applicant]
EP 1454657A2 · 2004 [cited by applicant]
EP 1815379B1 · 2018 [cited by applicant]
JP 2002222200A · 2002 [cited by applicant]
WO WO2016209858A1 · 2016 [cited by applicant]
“International Application Serial No. PCT/EP2020/061390, International Search Report dated Jul. 31, 2020”, (Jul. 31, 2020), 8 pgs. [cited by applicant]
“International Application Serial No. PCT/EP2020/061390, Written Opinion dated Jul. 31, 2020”, (Jul. 31, 2020), 11 pgs. [cited by applicant]
“United Kingdom Application Serial No. GB1905783.5, Search & Examination Report dated Oct. 10, 2019”, (Oct. 10, 2019), 9 pgs. [cited by applicant]
“Chinese Application Serial No. 202080046249.X, Office Action dated Dec. 23, 2023”, w English Translation, (Dec. 23, 2023), 18 pgs. [cited by applicant]
“Australian Application No. 2020261247, Examination Report dated Sep. 2, 2025”, (Sep. 2, 2025), 5 pgs. [cited by applicant]